{"meta":{"query_hash":"5c4433f12d4f","filters":{"venue":"Recent Patents on CNS Drug Discovery"},"cohort_total":3,"direct_labels_cover":0,"predictions_cover":3,"exported":3,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/5c4433f12d4f","api":"https://metacan.xera.ac/api/v1/cohort?venue=Recent+Patents+on+CNS+Drug+Discovery"},"results":[{"id":"W1966028568","doi":"10.2174/157488908783421500","title":"The Evolution of Pharmacological Treatment for Parkinsons Disease","year":2008,"lang":"en","type":"review","venue":"Recent Patents on CNS Drug Discovery","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Wilfrid Laurier University","funders":"","keywords":"Levodopa; Neuroprotection; Dopamine; Medicine; Pharmacology; Parkinson's disease; Monoamine oxidase; Neurodegeneration; Disease; Drug; Neuroscience; Psychology; Internal medicine; Chemistry","score_opus":0.08469904609985164,"score_gpt":0.3590730285850999,"score_spread":0.27437398248524825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966028568","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018298259,0.9959681,0.00018135234,0.0005150761,0.0002417698,0.0000066439316,0.000010221349,0.000011023534,0.0028828385],"genre_scores_gemma":[0.0008761148,0.9965114,0.0004184584,0.00045655598,0.00022771528,0.000008068127,0.000015325326,0.000002169495,0.0014840803],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972576,0.000051301275,0.00003687661,0.000044728233,0.00012319032,0.00001814366],"domain_scores_gemma":[0.99979836,0.000088693436,0.000031432603,0.0000090284575,0.000055097167,0.000017452336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054079376,0.0008632183,0.0011509779,0.0025907822,0.00038550384,0.0008687178,0.0007839933,0.0011043388,0.0041236435],"category_scores_gemma":[0.0004946544,0.00024295588,0.00048920594,0.0021697558,0.00063204474,0.0014474984,0.0006213265,0.002094816,0.0030168577],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004979558,0.00008247265,0.00012047021,0.007460368,0.000053463333,0.00029768108,0.00006923243,0.00019136388,0.0018280849,0.005142384,0.019001387,0.9657032],"study_design_scores_gemma":[0.000022076965,0.00009772199,0.00077729044,0.0021221465,0.00004579076,0.0015688713,0.000053734097,0.00006905414,0.00043999642,0.002422867,0.99236953,0.000010850327],"about_ca_topic_score_codex":0.001305337,"about_ca_topic_score_gemma":0.0020885833,"teacher_disagreement_score":0.0041236435,"about_ca_system_score_codex":0.00084985193,"about_ca_system_score_gemma":0.0009103345,"threshold_uncertainty_score":0.013795018},"labels":[],"label_agreement":null},{"id":"W2118727684","doi":"10.2174/157488906775245273","title":"The Astrocytic GABAA/Benzodiazepine-Like Receptor: The Joker Receptor for Benzodiazepine-Mimetic Drugs?","year":2006,"lang":"en","type":"review","venue":"Recent Patents on CNS Drug Discovery","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nickel Institute","funders":"","keywords":"Benzodiazepine; Flumazenil; GABAA receptor; Pharmacology; Receptor; Antagonist; Neuroscience; Medicine; Biology; Internal medicine","score_opus":0.09248717864817672,"score_gpt":0.36902029565424993,"score_spread":0.2765331170060732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118727684","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011328208,0.9218737,0.0051431437,0.04785893,0.0025311736,0.00003201461,0.00016576846,0.00017784715,0.01088922],"genre_scores_gemma":[0.09703354,0.8399985,0.005299981,0.021822117,0.0038420537,0.0000606466,0.00032392188,0.0000581826,0.03156095],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997315,0.000062129686,0.000024214616,0.000053440057,0.0000631777,0.00006555048],"domain_scores_gemma":[0.9998354,0.000028005084,0.000038748687,0.000012299044,0.000057666482,0.000027824803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059362216,0.0003766957,0.0010019714,0.00041161908,0.00022929368,0.0011199537,0.00079418306,0.0017524543,0.005227448],"category_scores_gemma":[0.00056771946,0.00017958276,0.0004227714,0.0003687288,0.0010415695,0.0028559556,0.0004542908,0.0013916622,0.004739548],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095969375,0.00013202718,0.0022408743,0.008824463,0.0001903225,0.004747196,0.00042736233,0.0004774957,0.105612785,0.043558247,0.09197609,0.7408535],"study_design_scores_gemma":[0.00008727293,0.00059533905,0.0034053787,0.001234429,0.00015440336,0.012165052,0.0004957777,0.0006297695,0.010079456,0.017375093,0.95369697,0.000081063255],"about_ca_topic_score_codex":0.00081199274,"about_ca_topic_score_gemma":0.0014819885,"teacher_disagreement_score":0.005227448,"about_ca_system_score_codex":0.0006651791,"about_ca_system_score_gemma":0.0006786567,"threshold_uncertainty_score":0.017487526},"labels":[],"label_agreement":null},{"id":"W2142289946","doi":"10.2174/157488912798842278","title":"Cannabinoids: Novel Medicines for the Treatment of Huntingtons Disease","year":2011,"lang":"en","type":"review","venue":"Recent Patents on CNS Drug Discovery","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"GW Pharmaceuticals","keywords":"Disease; Traditional medicine; Medicine; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.10443362434305038,"score_gpt":0.3696586428903049,"score_spread":0.26522501854725455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142289946","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008150025,0.9707963,0.0017566838,0.0034217695,0.0010020381,0.00006826822,0.00030287902,0.00012827544,0.014373697],"genre_scores_gemma":[0.04988785,0.9144666,0.0050775697,0.0041837487,0.00163366,0.00010678458,0.00062785955,0.00002984502,0.023986038],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988484,0.000013682523,0.000010382663,0.000019124123,0.00005484745,0.000017181676],"domain_scores_gemma":[0.9999337,0.000009628916,0.000016733833,0.0000028937593,0.00001971701,0.000017417167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002763815,0.00034952356,0.00038893698,0.001026499,0.00028118218,0.0005262167,0.00031067064,0.0007613073,0.004427661],"category_scores_gemma":[0.00019818515,0.00010568493,0.00032114462,0.0005935701,0.00031178363,0.0004956271,0.00052916317,0.0015041806,0.0022073141],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005160303,0.0003419911,0.00042700343,0.0039330027,0.00008063051,0.00085163646,0.00011251613,0.00024980062,0.054585844,0.0076435776,0.031599954,0.8996581],"study_design_scores_gemma":[0.00026785414,0.0007615119,0.0029474397,0.0009507771,0.00010843473,0.0027612096,0.00006025468,0.0003181335,0.01201382,0.0039371336,0.97583145,0.000042046297],"about_ca_topic_score_codex":0.00087498024,"about_ca_topic_score_gemma":0.0026924964,"teacher_disagreement_score":0.004427661,"about_ca_system_score_codex":0.0004318914,"about_ca_system_score_gemma":0.00039259062,"threshold_uncertainty_score":0.014812052},"labels":[],"label_agreement":null}]}